Prevalence of human papillomavirus detection in ovarian cancer: a meta-analysis
- PMID: 34086102
- PMCID: PMC8346400
- DOI: 10.1007/s10096-021-04282-7
Prevalence of human papillomavirus detection in ovarian cancer: a meta-analysis
Abstract
We conducted a meta-analysis of published data to update and estimate the prevalence of HPV in ovarian cancer. A comprehensive literature search was performed according to the PRISMA guidelines. Eligible articles published from 1989 until 2020 by searching Web of Sciences, Pubmed, Embase, and the Cochrane Library Central databases were gathered. A pooled estimation of HPV prevalence with a 95% confidence interval (CI) was calculated based on a random effect model. Quantitative assessment of heterogeneity was explored using Cochrane test and I2. Additionally, publication bias, sensitivity, meta-regression, and subgroup analyses were also performed. Twenty-nine studies involving 2280 patients with ovarian cancer were included. The statistical heterogeneity was high (I2 = 88%, P<0.0001). The pooled prevalence of HPV in ovarian cancer cases was 15.9% (95% CI, 11-22). In subgroup analyses, the highest prevalence of HPV was reported by studies from Asia (30.9%; 95% CI, 20-44) and Eastern Europe (29.3%; 95% CI, 4.4-78). Furthermore, the most frequently detected HPV genotype was HPV16 (54%; 95% CI, 27.9-55), followed by HPV18 (23.2%; 95% CI, 18.8-28.2). Our meta-analysis suggests a great difference in the prevalence of HPV detected in ovarian cancer by different studies, which is not seen in strongly HPV-associated cancers such as cervical cancer. However, the prevalence varied markedly by geographic region. Considering the substantial heterogeneity found, more studies with control groups and precise assays measuring HPV mRNA expression are needed to further evaluate the link and causative aetiology between HPV and ovarian cancer.
Keywords: Etiologic agent; HPV prevalence; Ovarian malignancy; Subgroup analysis; Worldwide.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Prevalence of human papillomavirus in epithelial ovarian cancer tissue. A meta-analysis of observational studies.Acta Obstet Gynecol Scand. 2014 Jan;93(1):6-19. doi: 10.1111/aogs.12254. Epub 2013 Oct 24. Acta Obstet Gynecol Scand. 2014. PMID: 24033121
-
Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis.Lancet Oncol. 2019 Jan;20(1):145-158. doi: 10.1016/S1470-2045(18)30682-X. Epub 2018 Dec 17. Lancet Oncol. 2019. PMID: 30573285
-
Prevalence and genotype distribution of human papillomavirus in cervical adenocarcinoma (usual type and variants): A systematic review and meta-analysis.J Med Virol. 2023 Oct;95(10):e29190. doi: 10.1002/jmv.29190. J Med Virol. 2023. PMID: 37861377
-
Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: A systematic review and meta-analysis.J Infect Public Health. 2020 Sep;13(9):1304-1313. doi: 10.1016/j.jiph.2020.06.012. Epub 2020 Jun 18. J Infect Public Health. 2020. PMID: 32564935
-
Human papillomavirus genotyping and integration in ovarian cancer Saudi patients.Virol J. 2013 Nov 20;10:343. doi: 10.1186/1743-422X-10-343. Virol J. 2013. PMID: 24252426 Free PMC article.
Cited by
-
Association of human papillomavirus 16 and 18 with ovarian cancer risk: Insights from a meta‑analysis.Oncol Lett. 2024 Sep 19;28(6):556. doi: 10.3892/ol.2024.14689. eCollection 2024 Dec. Oncol Lett. 2024. PMID: 39355783 Free PMC article.
-
Etiopathogenesis of ovarian cancer. An inflamm-aging entity?Gynecol Oncol Rep. 2022 Jun 11;42:101018. doi: 10.1016/j.gore.2022.101018. eCollection 2022 Aug. Gynecol Oncol Rep. 2022. PMID: 35719320 Free PMC article. Review.
-
Human Papillomaviruses and Malignant Neoplasms of the Female Upper Reproductive Tract: A Comprehensive Review of the Literature.Cancers (Basel). 2025 Jun 15;17(12):1995. doi: 10.3390/cancers17121995. Cancers (Basel). 2025. PMID: 40563645 Free PMC article. Review.
-
Equus caballus Papillomavirus Type-9 (EcPV9): First Detection in Asymptomatic Italian Horses.Viruses. 2022 Sep 15;14(9):2050. doi: 10.3390/v14092050. Viruses. 2022. PMID: 36146856 Free PMC article.
-
Human Papilloma Virus: An Unraveled Enigma of Universal Burden of Malignancies.Pathogens. 2023 Apr 6;12(4):564. doi: 10.3390/pathogens12040564. Pathogens. 2023. PMID: 37111450 Free PMC article. Review.
References
-
- Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G, Gjerstorff ML, Hatcher J, Johannesen TB, McGahan CE, Meechan D, Middleton R, Tracey E, Turner D, Richards MA, Rachet B. Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol. 2012;127(1):75–82. doi: 10.1016/j.ygyno.2012.06.033. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical